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INTRODUCTION AND OBJECTIVES:
Neonatal care advancements have increased
the survival of premature babies, who often
have morbidities requiring feedings via
nasogastric (NG) or G tube (Figure 1). The
reason for feeding problems may be
multifactorial, leading to different outcomes
for NG and G tube use. An NG tube is
preferred for short-term use to prevent
complications from GT placement. For longterm assistance, GT is recommended for its
stability, lower potential for respiratory
complications, and superior anthropometric
outcomes. However, in many cases it is not
possible to anticipate how long a feeding tube
may be needed. We reviewed charts of NICU
patients with GT placement regarding length
of time of GT use to identify patients who
could have been discharged with NG tube
and avoided surgery.
The aim of this pilot study of NICU babies
was to predict the need for tube feedings of a
duration >2 months so that patients with a
requirement of <2 months can be discharged
with an NG tube, thereby decreasing the risks
of GT placement and decreasing the cost of
health care. A larger study can identify
clinical characteristics that may help
determine the duration of feeding assistance
needed in NICU babies.
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Figure 1. Nasogastric (NG) tube feeding
(left) and gastrostomy tube (GT) feeding in
an infant
METHODS: A retrospective chart review
was done for patients (n=156) with GT in
NICU from January 2011 to May 2015.
Patients were followed up regarding GT use
until GT removal or for >1 year. Clinical
parameters were compared between patients
requiring GT for <2 months (n=29) vs. >2
months (n=124). Logistic regression
statistical analysis was used to identify
parameters that can predict short-term GT
need.
RESULTS: Of 156 patients, 3 were excluded
(lost to follow up). There were 29 patients
who used the GT for <2 months and 124
patients who used the GT for >2 months.
Model 1 factored in the effects of birth
weight, percent PO intake at time of GT
placement, presence of chromosomal
abnormality, and presence of CNS disease
(Figure 2). There was an interaction between
birth weight and presence of chromosomal
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abnormality. A 1-unit increase in percent PO
intake at time of GT placement had a 3%
significant decrease in odds of having the GT
for >2 months (P=0.005). Among babies with
a chromosome abnormality, there was a 0.2%

Figure 2. As birth weight increases, the
probability of GT use for >2 months
increases in the presence of a chromosome
abnormality and stays the same in the
absence of a chromosome abnormality.
significant increase in odds of having the GT
for >2 months for every 1-gram increase in
weight compared to babies that do not have a
chromosome abnormality (P=0.049).
Model 2 factored in the effects of gender,
gestational age, delivery method, presence of
CNS disease, presence of GI disease,
presence of lung disease, and presence of
other disease (Figure 3). There was an
interaction between the presence of CNS
disease and gestational age. Among babies
with a CNS disease, there was an 18%
significant increase in odds of having the GT
for >2 months for every 1-unit increase in
gestational age compared to babies that do
not have a CNS disease (P=0.048).
The following parameters were not
significantly different between the two
groups of patients: cardiovascular disease,
cleft palate, renal disease, infant of diabetic
mother, intrauterine growth restriction, other
disease, GI consult obtained before
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procedure, postoperative complications, and
GT removal (data not shown).

Figure 3. As gestational age increases, the
probability of GT use for >2 months
increases in the presence of CNS disease and
decreases in the absence of CNS disease.
CONCLUSIONS:
1. Higher percentage PO intake at time of
GT placement was associated with shortterm GT use.
2. Longer-term GT need may be predicted
by presence of chromosome abnormality
for babies with higher birth weights.
3. Longer-term GT need may be predicted
by presence of CNS disease for higher
gestational age babies.
4. Statistical analysis was limited by the
number of patients. Future research
including a larger number of patients who
used a GT for <2 months can yield more
insight into clinical parameters that may
be used to determine the need for NG vs.
G tube in NICU babies to minimize risks
and optimize outcomes.
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